Skip to main content
. Author manuscript; available in PMC: 2017 Apr 4.
Published in final edited form as: Thromb Haemost. 2017 Jan 19;117(4):691–699. doi: 10.1160/TH16-11-0834

Fig. 2. Plasma ADAMTS13 activity and the ratio of ADAMTS13 activity to VWFAg in patients with SAH and healthy controls.

Fig. 2

Plasma ADAMTS13 activity (A) was determined by the cleavage of rF-VWF73 as described in the Method. The ratios of plasma ADAMTS13 activity to VWFAg in patients and controls are shown in B. ANOVA with Kruskal-Wallis test was used to determine the statistical significance between the each PBD and the control. All p values were <0.0001, indicating that the difference was statistically highly significant between patients at each PBD and control.